§ BIOTECHNOLOGY
USD · BiotechnologyLCTX
LINEAGE CELL THERAPEUTICS IN
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
63 increased/new, 31 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 49.6M | 5.5% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.3M | n/a | n/a |
| Defender Capital, LLC. | 6.7M | 3.8% | −1% |
| Millennium Management | 5.6M | 0.0% | +164% |
| RAFFLES ASSOCIATES LP | 5.4M | 7.4% | ±0% |
| FIFTH THIRD BANCORP | 4.6M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for LCTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER51.7% · 0 holders
OTHER36.3% · 101 holders
DEALER / BANK4.7% · 16 holders
PASSIVE / INDEX2.6% · 3 holders
TACTICAL / MACRO2.3% · 3 holders
SYSTEMATIC / QUANT2.2% · 5 holders
QUALITY / COMPOUNDER0.1% · 2 holders
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for LCTX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention LCTX yet.